胰岛素基因增强结合蛋白2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 胰岛素基因增强结合蛋白2抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Islet-2 (insulin gene enhancer protein ISL-2) is a 359 amino acid protein encoded by the human gene ISL2. Islet-2 is a nuclear protein that contains two N-terminal LIM domains, followed by a homeodomain and a serine/ glutamine/threonine-rich C-terminus. Islet-2 is a transcriptional factor that defines subclasses of motor neurons that segregate into columns in the spinal cord and select distinct axon pathways. Islet-1 and Islet-2 are initially ex-pressed by all postmitotic spinal motor neurons prior to diversification of somatic and visceral neuronal fates. Somatic, but not visceral, motor胰岛素基因增强结合蛋白2抗体 neurons maintain Islet-2 expression at later embryonic stages. An early phase of Islet-2 expression by prospective visceral motor neurons of the sympathetic preganglionic motor column is critical for the emergence of complete visceral motor neuron character. Mutations that reduce or eliminate both Islet-1 and Islet-2 activity will result in pronounced defects in visceral motor neuron generation and eroded somatic motor neuron character.

胰岛素基因增强结合蛋白2抗体Also known as:

Insulin gene enhancer protein ISL 2; Insulin gene enhancer protein ISL-2; Insulin gene enhancer protein ISL2; ISL 2; ISL 2 transcription factor; ISL 2 transcription factor LIM/homeodomain; ISL2; ISL2 transcription factor; ISL2 transcription factor LIM/homeodomain; ISL2_HUMAN; Islet-2; Islet2; FLJ10160.

Specificity:

●

Rabbit Polyclonal IgG,胰岛素基因增强结合蛋白2抗体 affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Islet 2.

●

胰岛素基因增强结合蛋白2抗体Predicted Molecular Weight: 40kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl235Ra01补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)

kl235Rb51补体1抑制因子(C1INH)多克隆抗体Polyclonal Antibody to Complement 1 Inhibitor (C1INH)

kl238Hu01酪氨酸酶(TYR)多克隆抗体Polyclonal Antibody to Tyrosinase (TYR)

kl238Ra01酪氨酸酶(TYR)多克隆抗体Polyclonal Antibody to Tyrosinase (TYR)

kl243Hu01对氧磷酶1(PON1)多克隆抗体Polyclonal Antibody to klaoxonase 1 (PON1)

kl243Mu01对氧磷酶1(PON1)多克隆抗体Polyclonal Antibody to klaoxonase 1 (PON1)

kl243Ra01对氧磷酶1(PON1)多克隆抗体Polyclonal Antibody to klaoxonase 1 (PON1)

kl244Hu01胱天蛋白酶2(CASP2)多克隆抗体Polyclonal Antibody to Caskle 2 (CASP2)

kl249Hu01Nischarin蛋白(NISCH)多克隆抗体Polyclonal Antibody to Nischarin (NISCH)

kl252Bo01载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl252Ca01载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl252Hu01载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl252Mu01载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl252Ra01载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl252Rb51载脂蛋白C1(APOC1)多克隆抗体Polyclonal Antibody to Apolipoprotein C1 (APOC1)

kl253Hu01麦芽糖酶糖化酶(MGA)多克隆抗体Polyclonal Antibody to Maltase Glucoamylase, Intestinal (MGA)

kl259Bo01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)